BOSTON, Oct. 25, 2017 /PRNewswire/ -- From October 25-27, the DentaQuest Foundation is
The theme of this year's convening, "A Unified Voice: Messaging to Mobilizing," focuses on aligning the network's efforts around communications and messaging. This includes conversations on the historical factors that have contributed to the current oral health discourse, strategies for reframing communications to improve the public perception of oral health, and a discussion on facilitating more productive conversations around difficult topics, like racism and equity.
"It is awe-inspiring to see this many advocates and partners come together in support of our common cause of improving oral health," said Mike Monopoli, Executive Director of the DentaQuest Foundation. "The time has come for the network to speak out, with a unified voice, for the right of all people to be healthy."
The convening will welcome such notable speakers as Mary Otto, journalist and author of Teeth: The Story of Beauty, Inequality, and the Struggle for Oral Health America, and Tom Ashbrook, host of NPR's "On Point" radio show. Dr. Camara Jones, senior fellow at Morehouse School of Medicine and noted health equity expert, will lead a session on understanding the roots and cost of structural racism, and how it impacts health and health equity.
Learn more about the gathering by following a livestream of the Twitter feed, using the hashtag #OH2020. Follow the network on Twitter, @OralHealth2020.
CONTACT: Katie Leonard EMAIL: Katie.email@example.com PHONE: 857-363-0911
View original content:http://www.prnewswire.com/news-releases/dentaquest-foundation-grantees-and-partners-come-together-at-fifth-annual-oral-health-2020-national-network-gathering-300542985.html
SOURCE DentaQuest Foundation
Subscribe to our Free Newsletters!
Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and ...
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...View All